Related references
Note: Only part of the references are listed.Weathering the COVID-19 storm: Lessons from hematologic cytokine syndromes
James T. England et al.
BLOOD REVIEWS (2021)
Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro
Manli Wang et al.
CELL RESEARCH (2020)
Atorvastatin inhibits IL-17A, TNF, IL-6, and IL-10 in PBMC cultures from patients with severe rheumatoid arthritis
Priscilla Stela Santana de Oliveira et al.
IMMUNOBIOLOGY (2020)
Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China
Qiurong Ruan et al.
INTENSIVE CARE MEDICINE (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
COVID-19: combining antiviral and anti-inflammatory treatments
Justin Stebbing et al.
LANCET INFECTIOUS DISEASES (2020)
Anti-HCV, nucleotide inhibitors, repurposing against COVID-19
Abdo A. Elfiky
LIFE SCIENCES (2020)
Favipiravir, an anti-influenza drug against life-threatening RNA virus infections
Kimiyasu Shiraki et al.
PHARMACOLOGY & THERAPEUTICS (2020)
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report
J. -M. Michot et al.
ANNALS OF ONCOLOGY (2020)
Sofosbuvir as Repurposed Antiviral Drug Against COVID-19: Why Were We Convinced to Evaluate the Drug in a Registered/Approved Clinical Trial?
Babak Sayad et al.
ARCHIVES OF MEDICAL RESEARCH (2020)
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy
Paola Toniati et al.
AUTOIMMUNITY REVIEWS (2020)
Dysregulation of Immune Response in Patients With Coronavirus 2019 (COVID-19) in Wuhan, China
Chuan Qin et al.
CLINICAL INFECTIOUS DISEASES (2020)
COVID-19: lambda interferon against viral load and hyperinflammation
Evangelos Andreakos et al.
EMBO MOLECULAR MEDICINE (2020)
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
Jesus Villar et al.
LANCET RESPIRATORY MEDICINE (2020)
COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome
Toshio Hirano et al.
IMMUNITY (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19
Tobias Herold et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Favipiravir, an antiviral for COVID-19?
Eric A. Coomes et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2020)
Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency
Calvin J. Gordon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
COVID-19 and emerging viral infections: The case for interferon lambda
Ludmila Prokunina-Olsson et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
Cytokine release syndrome in severe COVID-19
John B. Moore et al.
SCIENCE (2020)
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Philippe Gautret et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Clinical efficacy of hydroxychloroquine in patients with covid-19 pneumonia who require oxygen: observational comparative study using routine care data
Matthieu Mahevas et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
COVID-19: consider cytokine storm syndromes and immunosuppression
Puja Mehta et al.
LANCET (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Meta-analysis of Effect of Statins in Patients with COVID-19
Chia Siang Kow et al.
AMERICAN JOURNAL OF CARDIOLOGY (2020)
Tocilizumab Treatment for Cytokine Release Syndrome in Hospitalized Patients With Coronavirus Disease 2019 Survival and Clinical Outcomes
Christina C. Price et al.
CHEST (2020)
Historically controlled comparison of glucocorticoids with or without tocilizumab versus supportive care only in patients with COVID-19-associated cytokine storm syndrome: results of the CHIC study
Sofia Ramiro et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Amelioration of COVID-19-related cytokine storm syndrome: parallels to chimeric antigen receptor-T cell cytokine release syndrome
Ryan L. Hoiland et al.
BRITISH JOURNAL OF HAEMATOLOGY (2020)
Impact of tocilizumab on mortality and/or invasive mechanical ventilation requirement in a cohort of 206 COVID-19 patients
Timothee Klopfenstein et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
IL-6-based mortality risk model for hospitalized patients with COVID-19
Rocio Laguna-Goya et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2020)
Experience with tocilizumab in severe COVID-19 pneumonia after 80 days of follow-up: A retrospective cohort study
Oscar Moreno-Perez et al.
JOURNAL OF AUTOIMMUNITY (2020)
Can we use interleukin-6 (IL-6) blockade for coronavirus disease 2019 (COVID-19)-induced cytokine release syndrome (CRS)?
Bingwen Liu et al.
JOURNAL OF AUTOIMMUNITY (2020)
Inhibition of SARS-CoV-2 by type I and type III interferons
Ulrike Felgenhauer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2020)
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
J. M. Molina et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19
A. B. Cavalcanti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A cheap steroid is the first drug shown to reduce death in COVID-19 patients
Kai Kupferschmidt
SCIENCE (2020)
Type III interferons disrupt the lung epithelial barrier upon viral recognition
Achille Broggi et al.
SCIENCE (2020)
Sofosbuvir as a potential alternative to treat the SARS-CoV-2 epidemic
Rodrigo Jacome et al.
SCIENTIFIC REPORTS (2020)
SARS-CoV-2 multifaceted interaction with human host. Part I: What we have learnt and done so far, and the still unknown realities
Genevieve P. Delcuve et al.
IUBMB LIFE (2020)
SARS-CoV-2 multifaceted interaction with the human host. PartII: Innate immunity response, immunopathology, and epigenetics
Tasnim H. Beacon et al.
IUBMB LIFE (2020)
Zinc sulfate in combination with a zinc ionophore may improve outcomes in hospitalized COVID-19 patients
Philip M. Carlucci et al.
JOURNAL OF MEDICAL MICROBIOLOGY (2020)
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?
R. Derwand et al.
MEDICAL HYPOTHESES (2020)
Statin Use Is Associated with Decreased Risk of Invasive Mechanical Ventilation in COVID-19 Patients: A Preliminary Study
Sophia L. Song et al.
PATHOGENS (2020)
Treatment of Severe COVID-19 with Tocilizumab Mitigates Cytokine Storm and Averts Mechanical Ventilation during Acute Respiratory Distress: A Case Report and Literature Review
Faryal Farooqi et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2020)
Ribavirin: pharmacology, multiple modes of action and possible future perspectives
Kristina Nystroem et al.
FUTURE VIROLOGY (2019)
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine
Raffaella Catalano et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Hydroxychloroquine efficiently suppresses inflammatory responses of human class-switched memory B cells via Toll-like receptor 9 inhibition
Masataka Torigoe et al.
CLINICAL IMMUNOLOGY (2018)
Selective DOT1L, LSD1, and HDAC Class I Inhibitors Reduce HOXA9 Expression in MLL-AF9 Rearranged Leukemia Cells, But Dysregulate the Expression of Many Histone-Modifying Enzymes
Ryan Lillico et al.
JOURNAL OF PROTEOME RESEARCH (2018)
Monocyte-derived IL-1 and IL-6 are differentially required for cytokine-release syndrome and neurotoxicity due to CAR T cells
Margherita Norelli et al.
NATURE MEDICINE (2018)
CAR T cell-induced cytokine release syndrome is mediated by macrophages and abated by IL-1 blockade
Theodoros Giavridis et al.
NATURE MEDICINE (2018)
FDA Approval Summary: Tocilizumab for Treatment of Chimeric Antigen Receptor T Cell-Induced Severe or Life-Threatening Cytokine Release Syndrome
Robert Q. Le et al.
ONCOLOGIST (2018)
Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
Maria L. Agostini et al.
MBIO (2018)
Efficacy analysis of hydroxychloroquine therapy in systemic lupus erythematosus: a study on disease activity and immunological biomarkers
Seyed Mostafa Monzavi et al.
INFLAMMOPHARMACOLOGY (2018)
Association between leptin and IL-6 concentrations with cardiovascular risk in patients with rheumatoid arthritis
Jose Antonio De Jesus Batun-Garrido et al.
CLINICAL RHEUMATOLOGY (2018)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Chloroquine triggers Epstein-Barr virus replication through phosphorylation of KAP1/TRIM28 in Burkitt lymphoma cells
Xiaofan Li et al.
PLOS PATHOGENS (2017)
Ribavirin restores IFNα responsiveness in HCV-infected livers by epigenetic remodelling at interferon stimulated genes
Barbara Testoni et al.
GUT (2016)
Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases
Daniella M. Schwartz et al.
NATURE REVIEWS RHEUMATOLOGY (2016)
Safe and Sensitive Antiviral Screening Platform Based on Recombinant Human Coronavirus OC43 Expressing the Luciferase Reporter Gene
Liang Shen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2016)
Developments with investigational Janus kinase inhibitors for rheumatoid arthritis
Luca Semerano et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2016)
The Interactome of the Glucocorticoid Receptor and Its Influence on the Actions of Glucocorticoids in Combatting Inflammatory and Infectious Diseases
Ioanna Petta et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2016)
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Travis K. Warren et al.
NATURE (2016)
BCX4430-A broad-spectrum antiviral adenosine nucleoside analog under development for the treatment of Ebola virus disease
Raymond Taylor et al.
JOURNAL OF INFECTION AND PUBLIC HEALTH (2016)
Hydroxychloroquine reduces microglial activity and attenuates experimental autoimmune encephalomyelitis
Marcus W. Koch et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2015)
IL-6 as a keystone cytokine in health and disease
Christopher A. Hunter et al.
NATURE IMMUNOLOGY (2015)
Ribavirin as a tri-targeted antitumor repositioned drug
Erick De La Cruz-Hernandez et al.
ONCOLOGY REPORTS (2015)
Screening of an FDA-Approved Compound Library Identifies Four Small-Molecule Inhibitors of Middle East Respiratory Syndrome Coronavirus Replication in Cell Culture
Adriaan H. de Wilde et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Current concepts in the diagnosis and management of cytokine release syndrome
Daniel W. Lee et al.
BLOOD (2014)
]Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis
K. Migita et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Simvastatin inhibits cytokines in a dose response in patients with rheumatoid arthritis
Michelly Cristiny Pereira et al.
INFLAMMATION RESEARCH (2014)
Protection against filovirus diseases by a novel broad-spectrum nucleoside analogue BCX4430
Travis K. Warren et al.
NATURE (2014)
Hydroxychloroquine decreases Th17-related cytokines in systemic lupus erythematosus and rheumatoid arthritis patients
Juliana Cruz da Silva et al.
CLINICS (2013)
Effect of In Vitro and In Vivo Anakinra on Cytokines Production in Schnitzler Syndrome
David Launay et al.
PLOS ONE (2013)
The Ambiguous Base-Pairing and High Substrate Efficiency of T-705 (Favipiravir) Ribofuranosyl 5′-Triphosphate towards Influenza A Virus Polymerase
Zhinan Jin et al.
PLOS ONE (2013)
Coronaviruses Lacking Exoribonuclease Activity Are Susceptible to Lethal Mutagenesis: Evidence for Proofreading and Potential Therapeutics
Everett Clinton Smith et al.
PLOS PATHOGENS (2013)
Inhibition of the inflammatory cytokine tumor necrosis factor-alpha with etanercept provides protection against lethal H1N1 influenza infection in mice
Xunlong Shi et al.
CRITICAL CARE (2013)
G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of Glucocorticoid Receptor target genes
Danielle Bittencourt et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis
Tomoaki Mori et al.
INTERNATIONAL IMMUNOLOGY (2011)
KAP1 Protein: An Enigmatic Master Regulator of the Genome
Sushma Iyengar et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines
Alenka Kuznik et al.
JOURNAL OF IMMUNOLOGY (2011)
Ribavirin restores ESR1 gene expression and tamoxifen sensitivity in ESR1 negative breast cancer cell lines
Anne Sappok et al.
CLINICAL EPIGENETICS (2011)
Promoter chromatin remodeling of immediate-early genes is mediated through H3 phosphorylation at either serine 28 or 10 by the MSK1 multi-protein complex
Bojan Drobic et al.
NUCLEIC ACIDS RESEARCH (2010)
Zn2+ Inhibits Coronavirus and Arterivirus RNA Polymerase Activity In Vitro and Zinc Ionophores Block the Replication of These Viruses in Cell Culture
Aartjan J. W. Te Velthuis et al.
PLOS PATHOGENS (2010)
Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells
Rayhana Rahim et al.
ANTI-CANCER DRUGS (2009)
The Tumor Necrosis Factor-α-blocking Agent Infliximab Inhibits Interleukin 1β (IL-1β) and IL-6 Gene Expression in Human Osteoblastic Cells
Estella Musacchio et al.
JOURNAL OF RHEUMATOLOGY (2009)
The versatile role of MSKs in transcriptional regulation
Linda Vermeulen et al.
TRENDS IN BIOCHEMICAL SCIENCES (2009)
Altered subcellular distribution of MSK1 induced by glucocorticoids contributes to NF-κB inhibition
Ilse Me Beck et al.
EMBO JOURNAL (2008)
Successful treatment of refractory lulms-associated haemophagocytic lymphohistiocytosis with infliximab
H. Ideguchi et al.
RHEUMATOLOGY (2007)
Cytokine storm in a phase 1 trial of the anti-CD28 monoclonal antibody TGN1412
Ganesh Suntharalingam et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
HDAC1 acetylation is linked to progressive modulation of steroid receptor-induced gene transcription
Yi Qiu et al.
MOLECULAR CELL (2006)
Chloroquine inhibits production of TNF-α, IL-1β and IL-6 from lipopolysaccharide-stimulated human monocytes/macrophages by different modes
C. -H. Jang et al.
RHEUMATOLOGY (2006)
Discovery of an RNA virus 3′→5′ exoribonuclease that is critically involved in coronavirus RNA synthesis
E Minskaia et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
New insights into the antiviral effects of chloroquine
A Savarino et al.
LANCET INFECTIOUS DISEASES (2006)
Histone deacetylase 2-mediated deacetylation of the glucocorticoid receptor enables NF-κB suppression
K Ito et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Success with infliximab in treating refractory hemophagocytic lymphohistiocytosis
T Henzan et al.
AMERICAN JOURNAL OF HEMATOLOGY (2006)
Repression of interleukin-5 transcription by the glucocorticoid receptor targets GATA3 signaling and involves histone deacetylase recruitment
YK Jee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Phosphorylation of ribavirin and viramidine by adenosine kinase and cytosolic 5′-nucleotidase II:: Implications for ribavirin metabolism in erythrocytes
JZ Wu et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Martin J. Vincent et al.
VIROLOGY JOURNAL (2005)
Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients
N Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
E Keyaerts et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study
JSM Peiris et al.
LANCET (2003)
A novel coronavirus associated with severe acute respiratory syndrome
TG Ksiazek et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Coronavirus-positive nasopharyngeal aspirate as predictor for severe acute respiratory syndrome mortality
OTY Tsang et al.
EMERGING INFECTIOUS DISEASES (2003)
Gold sodium thiomalate and chloroquine inhibit cytokine production in monocytic THP-1 cells through distinct transcriptional and posttranslational mechanisms
M Seitz et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2003)
Rapid induction of histone hyperacetylation and cellular differentiation in human breast tumor cell lines following degradation of histone deacetylase-1
Q Zhou et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Chloroquine interferes with lipopolysaccharide-induced TNF-α gene expression by a nonlysosomotropic mechanism
SM Weber et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
